Summary
Dysfunctional uterine bleeding, although not usually life-threatening, can cause disruption and discomfort for many women. It has often been poorly researched in the past, possibly because of the difficulty in measuring menstrual blood loss. Several different therapies are available and individual women can choose from a number of options. Nonsteroidal anti-inflammatory drugs such as mefenamic acid or indomethacin will be the first choice for many women as they have few side effects and it is only necessary to take them when menstrual bleeding occurs. When contraception is also required, combined oral contraceptives are helpful. Progestogen and danazol therapy are also effective, although side effects do occur. A new development has been the levonorgestrel-containing intrauterine contraceptive device which has been shown to result in large decreases in menstrual blood loss. For those women who would like a surgical approach but do not want to undergo hysterectomy, the relatively new technique of endometrial resection results either in amenorrhoea or reduced menstrual blood loss in the majority of women.
Similar content being viewed by others
References
Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology 97: 690–694, 1990
Cameron IT, Haining RH, Lumsden MA, Thomas VR, Smith SK. The effects of mefenamic acid and Norethisterone on measured menstrual blood loss. Obstetrics and Gynecology 76: 85–88, 1990
Chimbura TH, Anderson AB, Naish C, Cope E, Turnbull AC. Reduction of menstrual blood loss by Danazol in unexplained menorrhagia: lack of effect of placebo. British Journal of Obstetrics and Gynaecology 87: 1152–1158, 1980
Cohen BJB, Gibor Y. Anaemia and menstrual blood loss. Obstetrics and Gynecology Survey 35: 597–618, 1980
Dockeray CJ. The medical treatment of menorrhagia. In Chamberlain G (Ed.) Contemporary obstetrics and gynaecology, Butterworths, London, pp. 299–314, 1988
Dockeray CJ, Sheppard BL, Bonnar J. Comparison between mefenamic acid and Danazol in the treatment of established menorrhagia. British Journal of Obstetrics and Gynaecology 96: 840–844, 1989
Fraser IS. The treatment of menorrhagia with mefenamic acid. Research and Clinical Forums 5: 93–99, 1983
Fraser IS. Treatment of dysfunctional uterine bleeding with Danazol. Australian and New Zealand Journal of Obstetrics and Gynaecology 25: 224–226, 1985
Fraser IS, McCarron G, Markham R, Robinson M, Smythe E. Long term treatment of menorrhagia with mefenamic acid. Obstetrics and Gynecology 61: 109–112, 1983
Fraser IS, Pearse C, Shearman RP, Elliot PM, Mcllveer J, Markham R. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics and Gynecology 58: 543–551, 1981
Garry R. Hysteroscopic alternatives to hysterectomy. British Journal of Obstetrics and Gynaecology 97: 199–207, 1990
Hall P, Maclachlan N, Thorn N, Hudd MWE, Tayler CG, Garrioch DB. Control of menorrhagia by the cyclo-oxygenase inhibitors inaproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology 94: 554–558, 1987
Hallberg L, Nilsson L. Determination of menstrual blood loss. Scandinavian Journal of Clinical and Laboratory Investigation 16: 244–248, 1964
Hallberg L, Hogdahl A, Nilsson L, Rybo G. Menstrual blood loss — a population study. Acta Obstetricia et Gynecologica Scandinavica 45: 320–351, 1966
Haynes PJ, Flint APF, Hodgson H, Anderson A, Dray F, Turnball AC. Studies in menorrhagia a) mefenamic acid, b) endometrial prostaglandin concentrations. International Journal of Gynaecology and Obstetrics 17: 567–572, 1980
Haynes PJ, Hodgson H, Anderson ABM, Turnball AC. Measurement of menstrual blood loss in patients complaining of menorrhagia. British Journal of Obstetrics and Gynaecology 84: 763–768, 1977
Higham JM, O’Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. British Journal of Obstetrics and Gynecology 97: 734–739, 1990
Jeppsson S, Mellquist P, Ranneisk G. Short term effects of Danazol on endometrial histology. Acta Obstetricia et Gynecologica Scandinavica 123 (Suppl.): 41–44, 1984
Lewis BV. Hysteroscopy for the investigation of abnormal uterine bleeding. British Journal of Obstetrics and Gynaecology 97: 283–284, 1990
Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel-releasing intrauterine device. Annals of Medicine 22: 85–90, 1990
Macdonald R. Modern treatment of menorrhagia. British Journal of Obstetrics and Gynaecology 99: 3–6, 1992
Makarainen L, Ylikorkala O. Primary and myoma associated menorrhagia: role of prostaglandins and effects of ibuprofen. British Journal of Obstetrics and Gynaecology 93: 974–978, 1986
Nilsson L, Rybo G. Treatment of menorrhagia. American Journal of Obstetrics and Gynecology 110: 713–720, 1971
Ottosson UB, Johansson BG, von Schoultz B. Subfractions of high density lipoprotein cholesterol during estrogen replacement therapy. A comparison between progestogens and natural progesterone. American Journal of Obstetrics and Gynecology 151: 746–750, 1985
Rees MCP, Canete-Soler R, Lopez-Bernal A, Turnbull AC. Effects of fenamates on prostaglandin E receptor binding. Lancet 2: 541–542, 1988
Rydin E, Lundberg PO. Tranexamic acid and intracranial thrombosis. Lancet 2: 49, 1976
Siddle N, Sarnell P, Whitehad M. The effect of hysterectomy on the age of ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertility and Sterility 47: 94–100, 1987
Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology 88: 434–442, 1981
Teichmann AT, Wander H-E, Cremer P, Wieland H, Kuhn W, et al. Medroxyprogesterone acetate and lipid metabolic changes. Drug Research 37: 573–577, 1987
Wingo PA, Huezo CM, Rubin GL, Ory HW, Petersen HB. The mortality risk associated with hysterectomy. American Journal of Obstetrics and Gynecology 152: 803–808, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farquhar, C.M. Management of Dysfunctional Uterine Bleeding. Drugs 44, 578–584 (1992). https://doi.org/10.2165/00003495-199244040-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199244040-00005